Status:
COMPLETED
Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking Cessation
MindCotine Virtual Reality Mindful Exposure Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to see how feasible a mobile app based virtual reality program for smoking cessation (MindCotine) would be among Stanford cancer center patients
Eligibility Criteria
Inclusion
- Daily cigarette smoker or some day smoker (\>9 cigarettes per week)
- Age 18+
- English or Spanish fluent
- Smartphone compatibility
- Available to interact with a smartphone app for 6-weeks
- Available to complete the EOT assessment at end of 6-weeks
- Ability to understand and the willingness to personally sign the written IRB-approved informed consent document.
- Confirm phone, email, address during consent
Exclusion
- Ever had epilepsy
- Less than 10 cigarettes per week
- Not English or Spanish fluent
- No smartphone compatibility
- Unavailable to interact with the VR program,
- Unavailable to answer questions about the intervention post-treatment
Key Trial Info
Start Date :
October 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05220254
Start Date
October 18 2021
End Date
October 27 2022
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94305